Back

Introduction.

29 August 2020 (18:30 - 18:35)
Organised by:
Congress Presentation Part of: PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities Lipid-Lowering Agents Open Access ESC Congress 2020

About the speaker

Photo
Professor John Kastelein

Academic Medical Centre, Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
One year after: what are the implications of the new The ESC/EAS LDL-c Guidelines for PCSK9i?
Professor F. Mach (Geneva, CH)
Video
Presentation thumbnail
Five years of PCSK9i: Lessons from practice, which patients do benefit most?
Professor E. Stroes (Amsterdam, NL)
Video
Presentation thumbnail
Time to reduce the implementation gaps-the role of PCSK9i in routine practice
Professor K. Ray (London, GB)
Video
Presentation thumbnail
Discussion.
Professor J. Kastelein (Amsterdam, NL)
Video

Access the full session

Session thumbnail
PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
Video

The Event

Event poster

ESC Congress 2020

29 August 2020 18:30 CET
You may be interested in
thumbnail
Congress Session
The bigger picture: an expert assessment on the true impact of ATTR-cardiomyopathy
1 September 2024
thumbnail
Congress Presentation
Tocilizumab is associated with a lower incidence of major adverse cardiovascular events in Giant Cell Arteritis
29 August 2026
thumbnail
Congress Presentation
Only 1 in 5 european HF centres "always" initiate all four GDMT pillars during hospitalisation despite near-universal IV iron and uptitration capacity
30 August 2026
thumbnail
Congress Presentation
Navigating lower limb PAD diagnosis and treatment
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources